338 filings
Page 14 of 17
8-K
w0ihhgho7 2k53d
12 Mar 13
Unregistered Sales of Equity Securities
12:00am
8-K
hphwgb452 xeq5w
7 Mar 13
Pacira Pharmaceuticals, Inc. Reports 2012 Financial Results
12:00am
8-K
fzbn 760yh2j
23 Jan 13
Entry into a Material Definitive Agreement
12:00am
8-K
bpp9w
17 Jan 13
Pacira Pharmaceuticals, Inc. Announces Pricing of $110 Million Private Offering of Convertible Senior Notes
12:00am
8-K
ost2ua9at4k63w6
15 Jan 13
Results of Operations and Financial Condition
12:00am
8-K
vxqfgxz k4qv
15 Jan 13
Pacira Announces Proposed Offering of $100 Million of Convertible Senior Notes
12:00am
8-K
6wh7w7md79csh
7 Dec 12
Pacira Pharmaceuticals, Inc. and Aratana Therapeutics Inc. Enter into Global Licensing Agreement for Development and Commercialization
12:00am
8-K
ps5pi7izqi4gzf
4 Dec 12
Amendment #2 to Services Agreement
12:00am
8-K
e148kz
1 Nov 12
Pacira Pharmaceuticals, Inc. Reports $4.6 Million in Third Quarter EXPAREL® Revenue and Full Third Quarter 2012 Financial Results
12:00am
CT ORDER
smz66s6l
29 Aug 12
Confidential treatment order
12:00am
8-K
8o1fqph4
9 Aug 12
Pacira Pharmaceuticals, Inc. Reports $2.3 Million in Second Quarter EXPAREL® Revenue and Full Second Quarter 2012 Financial Results
12:00am
8-K
lz42en xl
3 Jul 12
Termination of a Material Definitive Agreement
12:00am
S-8
5erfkg3kcgscpd
7 Jun 12
Registration of securities for employees
12:00am
8-K
1zpnpc3zoq1y0efvej
7 Jun 12
Departure of Directors or Certain Officers
12:00am
8-K
tl8 zwkd7d0
18 May 12
Entry into a Material Definitive Agreement
12:00am
8-K
21i4o0nzt8hjaqxd
9 May 12
Pacira Pharmaceuticals, Inc. Reports First Quarter 2012 Financial Results
12:00am